- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01778608
Feasability Test of a Handset Device to Detect Levels of Sedation and Loss of Consciousness
April 16, 2024 updated by: University Medical Center Groningen
Feasibility Test of a Handset Device to Detect Sedation Levels and Loss of Consciousness During Propofol Administration
Sedation is often administered to relieve anxiety and discomfort during uncomfortable procedures in elderly patients.
Patient control of sedation offers many potential benefits for patients and healthcare professionals, including improved safety and patient satisfaction.
The investigators overall goal is to develop a patient controlled intravenous sedation system that is effective but very safe for the patient, and requires minimal supervision by a doctor or nurse.
To fulfill these criteria, a sedation system should incorporate fail-safe safety mechanisms.
A key safety-critical component is a method of objectively assessing the degree of sedation of the patient, and of preventing him from self-administering unsafe doses of the sedative drug.
The investigators have designed a new sedation system that uses a measure of the speed of response of the patient to a defined non-noxious stimulus to determine whether or not it is safe to allow him to self-administer further levels of sedation.
Before being able to execute a volunteer study in order to determine a rational selection of optimal threshold response time, a feasibility test on the handset device is required.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Groningen, Netherlands, 9700 RB
- University Medical Center Groningen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 72 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Twenty patients requiring anaesthesia for clinical surgical care.
ASA physical status I, II or III
Description
Inclusion Criteria:
- age 50-72 years
Exclusion Criteria:
- volunteer refusal
- patient age >72 years
- significant cardiovascular or respiratory disease
- latex allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Response times
Time Frame: Continuously shortly before (baseline)
|
Response time between non-noxious stimulus and activation of handset device
|
Continuously shortly before (baseline)
|
response time
Time Frame: during induction of anesthesia
|
Response time between non-noxious stimulus and activation of handset device
|
during induction of anesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
May 31, 2012
First Submitted That Met QC Criteria
January 24, 2013
First Posted (Estimated)
January 29, 2013
Study Record Updates
Last Update Posted (Actual)
April 18, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PCS-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Conscious Sedation
-
Menoufia UniversityCompleted
-
Ethicon Endo-SurgeryTerminated
-
Orion Corporation, Orion PharmaTerminated
-
University Hospital Inselspital, BerneGE HealthcareCompletedCritical Care | Conscious Sedation | Deep SedationSwitzerland
-
Indiana UniversityCompletedConscious SedationUnited States
-
Hadassah Medical OrganizationCompleted
-
University Medical Centre LjubljanaUnknown
-
Hospira, now a wholly owned subsidiary of PfizerMaruishi PharmaceuticalCompleted
-
University Hospital, Basel, SwitzerlandCompletedConscious SedationSwitzerland
-
Thomas HemmerlingCompletedConscious SedationCanada